Osaic Holdings’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Osaic Holdings’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,008	Closed	-$3.12K	–	7710
2023 Q2	$3.12K	Hold	2,008	–	–	﹤0.01%	6502
2023 Q1	$3.21K	Hold	2,008	–	–	﹤0.01%	6532
2022 Q4	$4K	Buy	2,008 +8	+0.4%	+$18	﹤0.01%	6461
2022 Q3	$4K	Hold	2,000	–	–	﹤0.01%	6565
2022 Q2	$9K	Hold	2,000	–	–	﹤0.01%	6206
2022 Q1	$6K	Buy	2,000 +1,960	+4,900%	+$23.8K	﹤0.01%	6442
2021 Q4	$1K	Sell	40 -1,020	-96%	-$24.2K	﹤0.01%	7335
2021 Q3	$32K	Buy	1,060 +1,040	+5,200%	+$29.4K	﹤0.01%	5453
2021 Q2	$1K	Hold	20	–	–	﹤0.01%	6958
2021 Q1	$1K	Hold	20	–	–	﹤0.01%	6768
2020 Q4	$1K	Hold	20	–	–	﹤0.01%	6355
2020 Q3	$3K	Hold	20	–	–	﹤0.01%	5801
2020 Q2	$3K	Buy	+20	New	+$3.33K	﹤0.01%	5736

Osaic Holdings's NBRV Position: Q3 2023 in Review

Osaic Holdings sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2023, closing a stake of 2,008 shares — an estimated $3.12K sold.

Osaic Holdings first reported a position in NBRV in Q2 2020 and held it in 13 quarters. The position peaked at $32K in Q3 2021. 0 funds tracked by Wall St. Rank hold NBRV as of Q3 2023.

Osaic Holdings reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2023 after selling out during the quarter.
Osaic Holdings sold 2,008 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2023, an estimated $3.12K.
Osaic Holdings first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 13 quarters.
Osaic Holdings's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $32K in Q3 2021.
0 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.